Immunize Your Child Against Malaria
Uganda has taken a significant step in combating malaria by launching the malaria vaccine into its routine immunization schedule, targeting children under 2 years old.
Malaria Vaccines:
• RTS,S/AS01: Recommended by the World Health Organization (WHO) for widespread use in children living in sub-Saharan Africa and other regions with moderate to high malaria transmission.
• R21/Matrix-M: Approved by WHO for use in malaria-endemic countries, expected to increase vaccine supply and benefit more children.
Benefits of Malaria Vaccination:
• Reduces uncomplicated malaria by approximately 40%.
• Decreases severe malaria by around 30%.
• Lowers all-cause mortality by 13%.
• Can be delivered alongside other control interventions like insecticide-treated nets and prompt malaria treatment.
Uganda’s Malaria Vaccine Rollout:
• 3.5 million doses to be distributed to children under 2 years old across 105 districts.
• Vaccine administered at 6, 7, 8, and 18 months.
• Partnership between Uganda’s Ministry of Health, PATH, WHO, Gavi, and UNICEF ensures successful implementation.
Key Partners:
• PATH: Providing technical and financial assistance for vaccine introduction and implementation.
• WHO: Recommending malaria vaccines and supporting country-level implementation
Gavi, the Vaccine Alliance: Funding vaccine procurement and supporting rollout.
• UNICEF: Collaborating on vaccine distribution and implementation.
No approved comments yet. You can start the conversation below.
Comments